2seventy bio, Inc.·4

Aug 7, 4:07 PM ET

Leschly Nick 4

4 · 2seventy bio, Inc. · Filed Aug 7, 2023

Insider Transaction Report

Form 4
Period: 2023-08-03
Leschly Nick
Director
Transactions
  • Sale

    Common Stock

    2023-08-03$6.13/sh9,060$55,4991,168,654 total
Holdings
  • Common Stock

    (indirect: By Trust)
    15,233
  • Common Stock

    (indirect: By Trust)
    41,000
Footnotes (3)
  • [F1]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.06 to $6.23, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]The Form 4 filed on July 19, 2022 inadvertently understated the Reporting Person's holdings by 133,500 shares, an error that was carried forward on subsequent filings. Column 5 of Table I reflects the number of shares of Issuer common stock beneficially owned by the Reporting Person following the reported transactions as of August 7, 2023.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT